Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer

Published:2020-12-29 Issue:2 Volume:14 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Uchino Yoshihiro¹,Muroya Daisuke²,Yoshitomi Munehiro²,Shichijo Shigeki¹,Yamada Akira³,Sasada Tetsuro⁴,Yamada Teppei⁵,Okuda Koji²,Itoh Kyogo¹,Yutani Shigeru¹

Affiliation:

1. Cancer Vaccine Center, Kurume University, Kurume, Fukuoka 839‑0823, Japan

2. Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan

3. Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka 830‑0011

4. Cancer Vaccine and Immunotherapy Center, Kanagawa Cancer Center Research Institute, Kanagawa, Yokohama 241‑8515, Japan

5. Department of Gastroenterological Surgery, Fukuoka University School of Medicine, Fukuoka 814‑0180, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP